Evidence map›Paper›PMID 42221463›Full record

ArticleThe Lancet regional health. Western Pacific2026

Incidence, recurrence, and determinants of sexually transmitted infections among people with HIV: a multicenter cohort study in China, 2010-2024, with implications for integrated HIV-STI prevention across the Western Pacific.

Xi Xiao, Liqin Sun, Yun He, Fang Zhao, Zixin Wang, Yanjun Li, Jinping Huang, Jinwei Wu, Yinsong Luo, Xiaorui Li and 6 more

Abstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xi XiaoSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Liqin SunDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Yun HeDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Fang ZhaoDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Zixin WangJC School of Public Health and Primary Care, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong, China.
Yanjun LiInfectious Disease Laboratory, Guangxi AIDS Clinical Treatment Center (Nanning), The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Jinping HuangInfectious Disease Laboratory, Guangxi AIDS Clinical Treatment Center (Nanning), The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Jinwei WuInfectious Disease Laboratory, Guangxi AIDS Clinical Treatment Center (Nanning), The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.
Yinsong LuoSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Xiaorui LiSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Chenye LiuSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Dian ZhaoSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Yiyao HuSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Jiaye LiuSchool of Public Health, Shenzhen University Medical School, Shenzhen, China.
Hongzhou LuDepartment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, China.
Ping CenInfectious Disease Laboratory, Guangxi AIDS Clinical Treatment Center (Nanning), The Fourth People's Hospital of Nanning, Nanning, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sexually transmitted infections (STIs) remain a major public health concern among people with HIV (PWH) in the Western Pacific region, where systematic long-term surveillance is limited. As the region's largest epidemic country, China has yet to generate longitudinal evidence on STI burden, recurrence, and risk determinants, emphasizing the urgency of integrated monitoring within HIV care systems. Methods: We established a multicenter dynamic cohort including 32,961 PWH who initiated ART between 2010 and 2024 at two major HIV treatment centers in southern China. Five major STIs-syphilis, human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2), gonorrhea, and chlamydia-were identified through linked clinical and laboratory records. Annual incidence rates were calculated, cumulative incidence was estimated using the Aalen-Johansen method, and demographic and clinical determinants were assessed using Fine-Gray models. Recurrence of viral infections and reinfection of bacterial STIs were identified by repeated laboratory-confirmed diagnoses during follow-up. Findings: From 2010 to 2024, 14.1% of participants experienced at least one STI after ART initiation, with the overall incidence of any STI increasing from 7.7 (95% CI 3.3-15.2) to 28.3 (95% CI 26.1-30.6) per 1000 person-years. Syphilis remained the leading infection, showing two distinct peaks in 2018 and 2024. HPV ranked second, with incidence rising steadily until 2021 before a modest decline. Gonorrhea and chlamydia resurged around 2022, while HSV-2 remained at a low but stable level. Younger age, male sex, and men who have sex with men were independent predictors of any STI. Higher baseline CD4 Interpretation: This long-term multicenter cohort provides the most comprehensive evidence to date on STI epidemiology among people with HIV in China. It reveals a persistently high burden of syphilis and HPV, a sharp resurgence of bacterial STIs, and notable recurrence of viral infections. These findings underscore the importance of strengthening comprehensive STI prevention and monitoring within HIV care settings, particularly through systematic screening and sustained surveillance efforts. By offering regionally relevant data, this study informs integrated HIV-STI control strategies and advances health equity across the Western Pacific. Funding: National Natural Science Foundation of China; the Guangxi Key Research and Development Program; the Guangdong Basic and Applied Basic Research Foundation; and the Guangdong Provincial Medical Science and Technology Research Fund Project.

Indexed as

EpidemiologyHIVIncidenceRecurrenceSexually transmitted infections

Identifiers

PMID42221463
PMCPMC13221911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.